State of New Jersey Common Pension Fund D Takes $433,000 Position in Celcuity, Inc. $CELC

State of New Jersey Common Pension Fund D bought a new position in shares of Celcuity, Inc. (NASDAQ:CELC) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,344 shares of the company’s stock, valued at approximately $433,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in CELC. Ogorek Anthony Joseph NY ADV acquired a new position in Celcuity during the 3rd quarter valued at about $27,000. US Bancorp DE lifted its holdings in shares of Celcuity by 25.4% in the third quarter. US Bancorp DE now owns 706 shares of the company’s stock valued at $35,000 after purchasing an additional 143 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Celcuity by 78.9% in the second quarter. BNP Paribas Financial Markets now owns 2,647 shares of the company’s stock valued at $35,000 after purchasing an additional 1,167 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Celcuity by 211.2% during the second quarter. Tower Research Capital LLC TRC now owns 5,549 shares of the company’s stock valued at $74,000 after buying an additional 3,766 shares during the last quarter. Finally, Versant Capital Management Inc grew its holdings in Celcuity by 611.2% during the third quarter. Versant Capital Management Inc now owns 1,593 shares of the company’s stock worth $79,000 after buying an additional 1,369 shares in the last quarter. Institutional investors and hedge funds own 63.33% of the company’s stock.

Insider Activity

In related news, Director Richard E. Buller sold 9,000 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the completion of the sale, the director owned 6,760 shares in the company, valued at approximately $949,509.60. This trade represents a 57.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director David Dalvey sold 25,000 shares of Celcuity stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $140.68, for a total transaction of $3,517,000.00. Following the completion of the sale, the director directly owned 65,000 shares in the company, valued at approximately $9,144,200. This represents a 27.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 37,000 shares of company stock valued at $5,111,950. 13.33% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Citizens Jmp increased their price target on Celcuity from $150.00 to $160.00 and gave the company a “market outperform” rating in a research report on Monday, May 4th. Craig Hallum reiterated a “buy” rating and issued a $189.00 target price on shares of Celcuity in a research note on Monday, May 4th. Citigroup reiterated an “outperform” rating on shares of Celcuity in a report on Monday, May 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Celcuity in a research report on Monday, April 20th. Finally, Wolfe Research restated an “outperform” rating and set a $110.00 price target on shares of Celcuity in a report on Thursday, March 12th. Ten research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $134.50.

Celcuity Stock Performance

Shares of Celcuity stock opened at $125.64 on Tuesday. The business’s fifty day simple moving average is $117.22 and its 200 day simple moving average is $105.30. The company has a current ratio of 10.55, a quick ratio of 10.55 and a debt-to-equity ratio of 3.20. Celcuity, Inc. has a 12 month low of $9.51 and a 12 month high of $151.02. The firm has a market capitalization of $6.07 billion, a P/E ratio of -33.15 and a beta of 0.09.

Celcuity (NASDAQ:CELC) last announced its quarterly earnings data on Wednesday, March 25th. The company reported ($0.97) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.09. As a group, analysts anticipate that Celcuity, Inc. will post -3.87 EPS for the current year.

Celcuity Company Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.